temozolomide has been researched along with gdc 0449 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakker, A; Benedetti, G; De Rosa, A; Ferruzzi, P; Giordano, C; Magnoni, L; Magrini, R; Mennillo, F; Miragliotta, V; Mori, E; Pericot Mohr, Gl; Rossi, M; Thomas, R; Tunici, P | 1 |
| Basu, A; Basu, P; Basu, SK; Bhattacharya, RN; Biswas, NK; Chandra, V; Chatterjee, A; Chattopadhyay, A; Das, S; Das, T; Dhara, S; Kumar, S; Maitra, A; Mukherjee, A; Sarkar-Roy, N; Tripathy, LN | 1 |
| Bureta, C; Komiya, S; Maeda, S; Nagano, S; Saitoh, Y; Sasaki, H; Setoguchi, T; Taniguchi, N; Tokumoto, H | 1 |
| Alicke, B; Choniawko, L; Forrest, WF; Gould, SE; Jakubczak, M; Mayba, O; Osinska, M; Piatkowski, P; Starr, A | 1 |
| Barritault, M; Bidaux, AS; Bonneville-Levard, A; Chinot, O; Frappaz, D; Garin, G; Hottinger, AF; Laigle-Donadey, F; Le Rhun, E; Meyronnet, D; Montané, L; Pérol, D | 1 |
2 trial(s) available for temozolomide and gdc 0449
| Article | Year |
|---|---|
Variant allele frequency enrichment analysis in vitro reveals sonic hedgehog pathway to impede sustained temozolomide response in GBM.
Topics: Alleles; Anilides; Cell Division; Cell Line, Tumor; Dacarbazine; Exome; Female; Follow-Up Studies; G2 Phase; Gene Frequency; Glioblastoma; Hedgehog Proteins; Humans; Male; Neoplasm Proteins; Pyridines; Radiography; Spheroids, Cellular; Temozolomide | 2015 |
MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.
Topics: Anilides; Cerebellar Neoplasms; Hedgehog Proteins; Humans; Medulloblastoma; Pyridines; Temozolomide | 2021 |
3 other study(ies) available for temozolomide and gdc 0449
| Article | Year |
|---|---|
In vitro and in vivo characterization of a novel Hedgehog signaling antagonist in human glioblastoma cell lines.
Topics: Anilides; Animals; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Gene Expression Profiling; Glioblastoma; Hedgehog Proteins; Humans; Mice; Mice, Nude; Pyridines; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor; Temozolomide; Transcription Factors; Veratrum Alkaloids; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2012 |
Synergistic effect of arsenic trioxide, vismodegib and temozolomide on glioblastoma.
Topics: Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Neoplasm Recurrence, Local; Pyridines; Signal Transduction; Temozolomide; Xenograft Model Antitumor Assays | 2019 |
Generalized Additive Mixed Modeling of Longitudinal Tumor Growth Reduces Bias and Improves Decision Making in Translational Oncology.
Topics: Anilides; Animals; Antineoplastic Agents, Alkylating; Bias; Decision Making; Disease Models, Animal; Female; Genes, Tumor Suppressor; Glioblastoma; Heterografts; Humans; Medical Oncology; Mice; Mice, Nude; Models, Statistical; Neoplasm Transplantation; Neoplasms; Normal Distribution; Patched-1 Receptor; Piperazines; Pyridines; Random Allocation; Statistics, Nonparametric; Temozolomide; Translational Research, Biomedical; Tumor Burden | 2020 |